Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Juneja

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
IJTLD Open|November 15, 2024
Experience of piloting BPaLM/BPaL for DR-TB care at selected sites in PakistanM A Khan, A Ismail, A Ghafoor, et al.
Blood|January 15, 2015
Elevated adenosine signaling via adenosine A2B receptor induces normal and sickle erythrocyte sphingosine kinase 1 activityKaiqi Sun, Yujin Zhang, Mikhail V Bogdanov, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|August 23, 2024
Experiences in the introduction of bedaquiline pretomanid linezolid for drug-resistant tuberculosis in KyrgyzstanB Myrzaliev, M Ahmatov, A Duishekeeva, et al.
Bone Marrow Transplantation|December 2, 2000
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, D Rischin, G C Toner, et al.
Bone Marrow Transplantation|April 1, 1999
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancerH M Prince, J Gardyn, M J Millward, et al.
Blood Advances|August 12, 2018
Elevated ecto-5'-nucleotidase: a missing pathogenic factor and new therapeutic target for sickle cell diseaseHong Liu, Morayo Adebiyi, Rong Rong Liu, et al.
Bone Marrow Transplantation|October 6, 2000
Docetaxel effectively mobilizes peripheral blood CD34+ cellsH M Prince, G C Toner, J F Seymour, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, M J Millward, D Rischin, et al.
Blood|March 1, 1996
A randomized study of high-dose cytarabine in induction in acute myeloid leukemiaJ F Bishop, J P Matthews, G A Young, et al.
Nature Medicine|December 21, 2010
Detrimental effects of adenosine signaling in sickle cell diseaseYujin Zhang, Yingbo Dai, Jiaming Wen, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
IJTLD Open|November 15, 2024
Experience of piloting BPaLM/BPaL for DR-TB care at selected sites in PakistanM A Khan, A Ismail, A Ghafoor, et al.
Blood|January 15, 2015
Elevated adenosine signaling via adenosine A2B receptor induces normal and sickle erythrocyte sphingosine kinase 1 activityKaiqi Sun, Yujin Zhang, Mikhail V Bogdanov, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|August 23, 2024
Experiences in the introduction of bedaquiline pretomanid linezolid for drug-resistant tuberculosis in KyrgyzstanB Myrzaliev, M Ahmatov, A Duishekeeva, et al.
Bone Marrow Transplantation|December 2, 2000
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, D Rischin, G C Toner, et al.
Bone Marrow Transplantation|April 1, 1999
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancerH M Prince, J Gardyn, M J Millward, et al.
Blood Advances|August 12, 2018
Elevated ecto-5'-nucleotidase: a missing pathogenic factor and new therapeutic target for sickle cell diseaseHong Liu, Morayo Adebiyi, Rong Rong Liu, et al.
Bone Marrow Transplantation|October 6, 2000
Docetaxel effectively mobilizes peripheral blood CD34+ cellsH M Prince, G C Toner, J F Seymour, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, M J Millward, D Rischin, et al.
Blood|March 1, 1996
A randomized study of high-dose cytarabine in induction in acute myeloid leukemiaJ F Bishop, J P Matthews, G A Young, et al.
Nature Medicine|December 21, 2010
Detrimental effects of adenosine signaling in sickle cell diseaseYujin Zhang, Yingbo Dai, Jiaming Wen, et al.
Pageof 15